Tromboprofilaxis, anticoagulación y coagulopatía en tiempos de pandemia: recomendación de la ACATA, ACMI, SCC CCV y ACMV

Gómez-Mesa, Juan E; Montenegro, Ana C; Gálvez, Kenny M; Molina, Dora I; Amed-Castillo, Gilberto; Echeverría, Luis E; Montes, María-Claudia; Galindo-Coral, Stephania.
Rev. colomb. cardiol ; 28(6): 539-547, nov.-dic. 2021. tab
Artículo en Español | LILACS, COLNAL | ID: biblio-1357228

Documentos relacionados

  1. Natural anticoagulants: A missing link in mild to moderate bleeding tendencies.
  2. Coagulation Abnormalities and Clinical Complications in Children With SARS-CoV-2: A Systematic Review of 48,322 Patients.
  3. COVID-19-associated coagulopathy in children: A multicenter observational cohort study.
  4. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
  5. Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation.
  6. Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients.
  7. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
  8. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
  9. [COVID-19-associated coagulopathy].
  10. Anticoagulation and Thrombotic Events in the Multisystem Inflammatory Syndrome in Children: Experience of a Single-center Cohort and Review of the Literature.